Objective To describe patient preferences in selecting specific biologics and compare clinical response using patient reported outcomes (PROs) among patients with rheumatoid arthritis (RA) started on different anti-tumor necrosis factor (TNF) therapies. 6 months. Results In all 267 patients with RA responded to the baseline survey of whom 57% preferred an injectable biologic 22 preferred… Continue reading Objective To describe patient preferences in selecting specific biologics and compare